Skip to content

Advertisement

Open Peer Review Reports for: Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
22 Jan 2017 Submitted Original manuscript
13 Mar 2017 Reviewed Reviewer Report - Seungtaek Choi
20 Mar 2017 Reviewed Reviewer Report - Jennifer Beebe-Dimmer
10 Apr 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 2
10 Apr 2017 Submitted Manuscript version 2
20 Jul 2017 Reviewed Reviewer Report - Jennifer Beebe-Dimmer
21 Jul 2017 Reviewed Reviewer Report - Seungtaek Choi
12 Sep 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 3
12 Sep 2017 Submitted Manuscript version 3
2 Oct 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 4
2 Oct 2017 Submitted Manuscript version 4
4 Nov 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 5
4 Nov 2017 Submitted Manuscript version 5
Publishing
13 Nov 2017 Editorially accepted
23 Nov 2017 Article published 10.1186/s12885-017-3775-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement